Delivery Order SPE2DR25D2014-SPE2DR26FA4J6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,850.14 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 26, 2026, with a completion date of January 27, 2026. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under full and open competition. The contractor, headquartered in Conshohocken, Pennsylvania, is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems....
- On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS, with an ultimate completion date of January 14, 2026. This is a firm fixed-price delivery order issued under a competitive process with no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is headquartered in Conshohocken, Pennsylvania, and serves as a critical pharmaceutical distributor to federal medical procurement programs, particularly...
- The Defense Logistics Agency awarded a $4,318.61 delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on February 3, 2026, with completion expected by February 4, 2026. This non-set-aside, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 and extending through December 2026. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,618.20 delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 14, 2026, with completion expected by January 15, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $2,850.14 to AmerisourceBergen Drug Corp for ACT-O-VIALS on January 30, 2026, with an ultimate completion date of February 2, 2026. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $1,992.15 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $12,228.81 to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 17, 2025, with an ultimate completion date of December 18, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,071.99 to AmerisourceBergen Drug Corp for ACT-O-VIALS on November 20, 2025, with an ultimate completion date of November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery supports the DLA's medical supply chain...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA4J6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,425.07 to AmerisourceBergen Drug Corp for ACT-O-VIALS on February 3, 2026, with a completion date of February 4, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The company's federal contract portfolio demonstrates consistent capability to deliver diverse pharmaceutical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and medical test kits across multiple therapeutic domains. This delivery order for ACT-O-VIALS continues the contractor's established role in fulfilling essential medical supply requirements for the Department of Defense healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/2/26 |